Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 594

Related Citations for PubMed (Select 19017280)

1.

Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Navazesh M, Mulligan R, Karim R, Mack WJ, Ram S, Seirawan H, Greenspan J, Greenspan D, Phelan J, Alves M; Oral Substudy of the Women's Interagency HIV Study Collaborative Study Group*.

Oral Dis. 2009 Jan;15(1):52-60. doi: 10.1111/j.1601-0825.2008.01456.x. Epub 2008 Nov 11.

2.

A 4-year longitudinal evaluation of xerostomia and salivary gland hypofunction in the Women's Interagency HIV Study participants.

Navazesh M, Mulligan R, Barrón Y, Redford M, Greenspan D, Alves M, Phelan J; Women's Interagency HIV Study participants.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jun;95(6):693-8.

PMID:
12789150
3.

The prevalence of xerostomia and salivary gland hypofunction in a cohort of HIV-positive and at-risk women.

Navazesh M, Mulligan R, Komaroff E, Redford M, Greenspan D, Phelan J.

J Dent Res. 2000 Jul;79(7):1502-7.

PMID:
11005735
4.

Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.

Berhane K, Karim R, Cohen MH, Masri-Lavine L, Young M, Anastos K, Augenbraun M, Watts DH, Levine AM.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52.

PMID:
15385731
5.

Salivary gland disease in human immunodeficiency virus-positive women from the WIHS study. Women's Interagency HIV Study.

Mulligan R, Navazesh M, Komaroff E, Greenspan D, Redford M, Alves M, Phelan J.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000 Jun;89(6):702-9.

PMID:
10846124
6.

The effect of HAART on salivary microbiota in the Women's Interagency HIV Study (WIHS).

Navazesh M, Mulligan R, Pogoda J, Greenspan D, Alves M, Phelan J, Greenspan J, Slots J.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Dec;100(6):701-8. Epub 2005 Jan 25.

PMID:
16301151
7.

Incidence of oral lesions in HIV-1-infected women: reduction with HAART.

Greenspan D, Gange SJ, Phelan JA, Navazesh M, Alves ME, MacPhail LA, Mulligan R, Greenspan JS.

J Dent Res. 2004 Feb;83(2):145-50.

PMID:
14742653
8.

Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.

Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.

Antivir Ther. 2005;10(1):73-81.

PMID:
15751765
9.

Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.

Ortega KL, Vale DA, Magalhães MH.

J Oral Pathol Med. 2009 Jul;38(6):489-94. doi: 10.1111/j.1600-0714.2009.00783.x. Epub 2009 Apr 28.

PMID:
19453845
10.

Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.

Golub ET, Benning L, Sharma A, Gandhi M, Cohen MH, Young M, Gange SJ.

Clin Infect Dis. 2008 Jan 15;46(2):305-12. doi: 10.1086/524752.

11.

Salivary secretion, mucin concentrations and Candida carriage in HIV-infected patients.

Jainkittivong A, Lin AL, Johnson DA, Langlais RP, Yeh CK.

Oral Dis. 2009 Apr;15(3):229-34. doi: 10.1111/j.1601-0825.2009.01514.x. Epub 2009 Feb 1.

PMID:
19207880
12.

Salivary secretory leukocyte protease inhibitor increases in HIV infection.

Lin AL, Johnson DA, Stephan KT, Yeh CK.

J Oral Pathol Med. 2004 Aug;33(7):410-6.

PMID:
15250833
13.

Major salivary gland output differs between users and non-users of specific medication categories.

Wolff A, Zuk-Paz L, Kaplan I.

Gerodontology. 2008 Dec;25(4):210-6. doi: 10.1111/j.1741-2358.2008.00223.x. Epub 2008 Feb 27.

PMID:
18312369
14.

Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.

Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503.

PMID:
11981366
15.

Hyposalivation, xerostomia and oral health status of HIV-infected subjects in Thailand before HAART era.

Nittayananta W, Chanowanna N, Jealae S, Nauntofte B, Stoltze K.

J Oral Pathol Med. 2010 Jan;39(1):28-34. doi: 10.1111/j.1600-0714.2009.00826.x. Epub 2009 Aug 26.

PMID:
19709350
16.

Salivary gland function in HIV-infected patients treated with highly active antiretroviral therapy (HAART).

Lin AL, Johnson DA, Sims CA, Stephan KT, Yeh CK.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Sep;102(3):318-24. Epub 2006 Mar 3.

PMID:
16920540
17.

Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study.

Hessol NA, Kalinowski A, Benning L, Mullen J, Young M, Palella F, Anastos K, Detels R, Cohen MH.

Clin Infect Dis. 2007 Jan 15;44(2):287-94. Epub 2006 Dec 12.

19.

Metabolic changes associated with antiretroviral therapy in HIV-positive patients.

Almeida SE, Borges M, Fiegenbaum M, Nunes CC, Rossetti ML.

Rev Saude Publica. 2009 Apr;43(2):283-90. Epub 2009 Feb 13.

20.

Natural history of HIV-associated salivary gland disease.

Schiødt M, Dodd CL, Greenspan D, Daniels TE, Chernoff D, Hollander H, Wara D, Greenspan JS.

Oral Surg Oral Med Oral Pathol. 1992 Sep;74(3):326-31.

PMID:
1407995
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk